Di Sciullo, M. P., Menay, F., Cocozza, F., Gravisaco, M. J., Waldner, C. I., & Mongini, C. (2019). Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma. Elsevier.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Di Sciullo, Maria Paula, Florencia Menay, Federico Cocozza, María José Gravisaco, Claudia Inés Waldner, and Claudia Mongini. Systemic Administration of Imiquimod as an Adjuvant Improves Immunogenicity of a Tumor-lysate Vaccine Inducing the Rejection of a Highly Aggressive T-cell Lymphoma. Elsevier, 2019.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Di Sciullo, Maria Paula, et al. Systemic Administration of Imiquimod as an Adjuvant Improves Immunogenicity of a Tumor-lysate Vaccine Inducing the Rejection of a Highly Aggressive T-cell Lymphoma. Elsevier, 2019.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.